JPMorgan Chase & Co’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $84.8M | Buy |
|
|||||
|
2025
Q2 | $43.5M | Sell |
|
|||||
|
2025
Q1 | $53.3M | Sell |
|
|||||
|
2024
Q4 | $76.1M | Buy |
|
|||||
|
2024
Q3 | $65.2M | Buy |
|
|||||
|
2024
Q2 | $60.2M | Buy |
|
|||||
|
2024
Q1 | $48.2M | Buy |
|
|||||
|
2023
Q4 | $23.7M | Sell |
|
|||||
|
2023
Q3 | $11.4M | Buy |
|
|||||
|
2023
Q2 | $12.2M | Buy |
|
|||||
|
2023
Q1 | $12.5M | Buy |
|
|||||
|
2022
Q4 | $14.3M | Buy |
|
|||||
|
2022
Q3 | $11.2M | Sell |
|
|||||
|
2022
Q2 | $9.16M | Buy |
|
|||||
|
2022
Q1 | $2.39M | Buy |
|
|||||
|
2021
Q4 | $2.45M | Buy |
|
|||||
|
2021
Q3 | $1.26M | Buy |
|
|||||
|
2021
Q2 | $589K | Buy |
|
|||||
|
2021
Q1 | $582K | Sell |
|
|||||
|
2020
Q4 | $614K | Sell |
|
|||||
|
2020
Q3 | $4.83M | Buy |
|
|||||
|
2020
Q2 | $3.53M | Sell |
|
|||||
|
2020
Q1 | $3.6M | Buy |
|
|||||
|
2019
Q4 | $1.13M | Buy |
|
|||||
|
2019
Q3 | $208K | Sell |
|
|||||
|
2019
Q2 | $477K | Buy |
|
|||||
|
2019
Q1 | $91K | Sell |
|
|||||
|
2018
Q4 | $74K | Buy |
|
|||||
|
2018
Q3 | $105K | Buy |
|
|||||
|
2018
Q2 | $77K | Sell |
|
|||||
|
2018
Q1 | $809K | Buy |
|
|||||
|
2017
Q4 | $712K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $3K | Hold |
|
|||||
|
2016
Q1 | $2K | Buy |
|
|||||
|
2015
Q4 | $2K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $224K | Buy |
|